JCR Pharmaceuticals

JCR Pharmaceuticals

JCR has been proactively engaged in research and development (R&D) of biopharmaceuticals based on recombinant DNA technologies.

HQ location
Kobe, Japan
Launch date
Employees
Market cap
$569m
Enterprise value
$777m
Share price
JPY619.00 4552.T
  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor

€0.0

round
N/A

N/A

IPO
Total Funding000k
TPG Biotech
TPG Biotech(exited)

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
JPY2022202320242025202620272028
Revenues0000000000000000000000000000
% growth70 %(33 %)25 %(23 %)16 %2 %(3 %)
EBITDA0000000000000000000000000000
% EBITDA margin44 %22 %25 %(11 %)11 %17 %14 %
Profit0000000000000000000000000000
% profit margin28 %11 %13 %(14 %)7 %6 %4 %
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000

Source: Company filings or news article, Equity research estimates

Notes (0)
More about JCR Pharmaceuticals
Made with AI
Edit

JCR Pharmaceuticals is a biopharmaceutical company specializing in the development and commercialization of innovative treatments for rare and intractable diseases. Operating primarily in the healthcare and biotechnology sectors, JCR Pharmaceuticals serves patients, healthcare providers, and research institutions. The company's business model focuses on leveraging advanced cell and gene therapy technologies to create effective and targeted treatments. Revenue is generated through the sale of proprietary drugs, licensing agreements, and collaborative research partnerships. JCR Pharmaceuticals aims to address unmet medical needs by providing cutting-edge solutions that improve patient outcomes and quality of life.

Keywords: biopharmaceutical, rare diseases, intractable diseases, cell therapy, gene therapy, healthcare, biotechnology, innovative treatments, patient outcomes, research partnerships.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by JCR Pharmaceuticals

Edit
ArmaGen Technologies
ACQUISITION by JCR Pharmaceuticals Mar 2020